Why the study?
Whether the early survival advantage of EVAR over open repair is maintained long term, or if open repair reduces long-term complications and reinterventions, remained questionable.
Does EVAR improve long-term survival compared to OAR in patients undergoing elective repair of intact abdominal aortic aneurysm?
Does EVAR improve long-term survival compared to OAR in patients undergoing elective repair of intact abdominal aortic aneurysm?
EVAR provides a perioperative survival benefit over OAR for intact AAA that lasts up to 3 years, but long-term survival is similar and EVAR requires more vascular reinterventions.
EVAR's 3-year survival edge in elective iAAA supports short-term preference; leaves long-term reintervention durability open for prospective trials.
Objective Endovascular aortic aneurysm repair (EVAR) has been established as a standard treatment option for intact abdominal aortic aneurysm (iAAA) and gained importance due to a lower perioperative mortality than open repair (OAR). However, whether this survival advantage can be maintained or if OAR is beneficial in terms of long-term complications and reinterventions remains questionable. Design In this retrospective cohort study data from patients undergoing elective EVAR or OAR for iAAAs in the years 2010-2016 was analyzed. The patients were followed through 2018. Methods In the propensity score matched cohorts the perioperative and long-term outcomes of the patients were assessed. We identified 20 683 patients undergoing elective iAAA repair (76.4% EVAR). The propensity matched cohorts included 4886 pairs of patients. Results The perioperative mortality was 1.9% for EVAR and 5.9% for OAR ( P = <.001). The perioperative mortality was mainly influenced by patients age (Odds-Ratio (OR):1.073, confidence interval (CI):1.058-1.088, P ≤ .001) and OAR (OR:3.242, CI:2.552-4.119, P ≤ .001). The early survival benefit after endovascular repair persisted for approximately 3 years (estimated survival EVAR 82.3%, OAR 80.9%, P = .021). After that time the estimated survival curves were similar. After 9 years the estimated survival was 51.2% after EVAR as compared to 52.8% after OAR ( P = .102). The operation method didn’t influence long-term survival significantly (Hazard-Ratio (HR): 1.046, CI: .975-1.122, P = .211). The vascular reintervention rate was 17.4% in the EVAR cohort and 7.1% in the OAR cohort ( P ≤ .001). Conclusion EVAR has a significantly lower perioperative mortality than OAR, a survival benefit that lasts up to 3 years after intervention. Thereafter, no significant difference in survival was observed between EVAR and OAR. The decision between EVAR or OAR may depend on patient preference, surgeons’ experience, and the institutions’ ability to handle complications.
No takes yet. Share an insight, caveat, or question.
Epple et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: